CVE-2022-24389

Authenticated Privileged Command Injection Vulnerability in Fidelis Network and Deception

Description

Vulnerability in rconfig “cert_utils” enables an attacker with user level access to the CLI to inject root level commands into Fidelis Network and Deception CommandPost, Collector, Sensor, and Sandbox components as well as neighboring Fidelis components. The vulnerability is present in Fidelis Network and Deception versions prior to 9.4.5. Patches and updates are available to address this vulnerability.

Remediation

Solution:

  • Apply patches or upgrade to latest version

Categories

8.8
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 1.03% Top 25%
Vendor Advisory zendesk.com
Affected: Fidelis Cybersecurity Fidelis Network
Affected: Fidelis Cybersecurity Fidelis Deception
Published at:
Updated at:

References

Link Tags
https://fidelissecurity.zendesk.com/hc/en-us/articles/6211730139411 vendor advisory permissions required

Frequently Asked Questions

What is the severity of CVE-2022-24389?
CVE-2022-24389 has been scored as a high severity vulnerability.
How to fix CVE-2022-24389?
To fix CVE-2022-24389: Apply patches or upgrade to latest version
Is CVE-2022-24389 being actively exploited in the wild?
It is possible that CVE-2022-24389 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-24389?
CVE-2022-24389 affects Fidelis Cybersecurity Fidelis Network, Fidelis Cybersecurity Fidelis Deception.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.